Verrica Pharmaceuticals Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $47.5M | $80.1M | $15.8M |
| FY2022 | $4.7M | $44.7M | $34.3M |
| FY2023 | $61.8M | $81.6M | $69.5M |
| FY2024 | $64.0M | $54.1M | $46.3M |
| FY2025 | $22.4M | $47.1M | $30.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $47.5M | $80.1M | $15.8M |
| FY2022 | $4.7M | $44.7M | $34.3M |
| FY2023 | $61.8M | $81.6M | $69.5M |
| FY2024 | $64.0M | $54.1M | $46.3M |
| FY2025 | $22.4M | $47.1M | $30.1M |